HPE Europe 2020

Register Today

JOIN THE CONVERSATION

In light of the COVID-19 pandemic, the third annual European Healthcare Private Equity Symposium will be conducted as a five-part webinar series, taking place over five weeks in a virtual tour across several European locations.

An industry that has undergone massive change in recent months, healthcare remains an active private equity market. However the landscape is now more complex and fast-paced than ever before. As a leading law firm for health and life sciences ventures globally, McDermott is uniquely positioned to bring together a panel of the preeminent voices in both the healthcare and private equity sectors.

You’ll hear from those on the cutting-edge about the trends that are driving deals and valuations in the European and international healthcare markets. Industry leaders will share their insights on reimbursement, regulatory changes and the impact of consolidation on the industry.

This fast-paced and collaborative series is exclusively available for senior leaders and investors in the global healthcare services industry.

This multipart HPE Europe Summer series will include the following webinars

Join us and be a part of the conversation with those at the forefront of the industry who are navigating this new healthcare landscape.

WEBINAR REPLAY:

 WEBINAR 1: WHERE DO THE OPPORTUNITIES EXIST?

June 23, 2020 3 PM in British Summer Time

An industry that is undergoing constant change, healthcare remains an active private equity / investment market. However, the landscape is now more complex and fast-paced than ever before. For that reason, we have put together a series of investment focused webinars for the healthcare industry.

We have a panel that covers a wide spectrum of experience including investors, operators, deal arrangers and advisors, commentators and providers of healthcare services and equipment. We will also look at different sub- sectors including the effects arising as a result of the current pandemic. Discussion topics include:

  • Which areas are of prime and growing interest from investors
  • Are there different health sub-sectors that have different investment profiles
  • How do investment strategies differ by health sub-sector
  • How does the current pandemic manifest itself in deal negotiations and underlying documentation (e.g., Material Adverse Circumstances, Force Majeure, termination, claw-backs)

This fast-paced and collaborative series is exclusively available for senior leaders and investors in the global healthcare services industry.

Speakers

Moderator

  • Hamid Yunis, Partner-in-Charge UK Heathcare Practice, McDermott Will & Emery

 

To download key takeaways from this session, please click here.

 For highlights from our speakers, please visit our Health & Life Sciences blog.

 

WEBINAR REPLAY:

WEBINAR 2: What are the life science transaction trends in the wake of the sanitary crisis?

June 29, 2020 4 PM in British Summer Time

Fresh from leading at the forefront of the pandemic, the life sciences industry now comes together and reacts to the uncertainty of the post-crisis market. Though the impact will be transient in the long-term, the full effects of the crisis should be contrasted across different segments of the life sciences sector. There will be strong opportunities post the crisis for companies with solid foundations.

The life sciences sector has moved from an in-house model to an increased reliance on partnering for R&D, manufacturing and logistics services, as well as for product acquisitions. During our upcoming webinar, attendees can expect to learn:

  • What specific deal trends and investment opportunities are emerging from the crisis?
  • How is deal making impacted?
  • What does greater investment into research and development mean for the next generation of scientific discovery?

Speakers

Moderator

 To download key takeaways from this session, please click here.

For highlights from our speakers, please visit our Health & Life Sciences blog.

WEBINAR REPLAY:

WEBINAR 3: What is the future landscape for Innovation, Medtech and Digital Health in the post Covid world for health investors and providers?

July 7, 2020 5:30 PM in British Summer Time

Health technology and digital health are fundamental to goals of delivering improvements in clinical outcomes and patient experience. These sectors had already seen significant investment and growth before the pandemic, but COVID-19 has highlighted the importance and opportunities in this sector.

During our upcoming webinar, attendees can expect to learn:

  • What have we learnt from COVID-19 as it relates to faster adoption of technologies and willingness to embrace new technology?
  • What are the key issues enabling the longer term adoption and acceleration of new technology?
  • Are there steps that governments can take to speed up technology adoption?
  • What are the key factors that providers and investors should consider when embarking on new investments in this space?

Speakers

Moderator

  • Sharon Lamb, Partner, McDermott Will & Emery (London)

To download key takeaways from this session, please click here.

For highlights from our speakers, please visit our Health & Life Sciences blog.

WEBINAR REPLAY:

To downWEBINAR 4: What’s the impact of recent regulation and government measures on investments in healthcare and life sciences in Europe?

July 9, 2020 3 PM in British Summer Time

The impact of COVID-19 triggered recent regulation and government measures on investments in healthcare and life sciences in Europe has been and will continue to be substantial. To move forward stakeholders must understand which changes stand to affect investment opportunities most and which will have long term implications.

Join our panel of industry experts and PE managers during our upcoming webinar, where attendees can expect to learn:

  • How the lockdown and severance and stimulus packages will affect investors’ decisions in health and life sciences in Europe
  • What the impact of accelerated authorization proceedings will be for clinical lab tests, vaccines and drugs in connection with COVID-19
  • How aggravated foreign investment control regimes will impact the health and life sciences sector during COVID-19

Speakers

  • Ben Faircloth, Partner and Global Co-head of Healthcare, L.E.K. Consulting
  • Karthic Jayaraman, Partner, TPG Captial
  • Max Müller, Head of Public Affairs Germany & EU, Bayer AG, Formerly CSO of DocMorris
  • Dr. Ulrich Wandschneider, Senior Advisor, Trilantic Capital Partners, Supervisory Board Member, Biontech SE, Formerly CEO of Asklepios Kliniken GmbH & Co.KGaA

Moderator

 

 To download key takeaways from this session, please click here.

 For highlights from our speakers, please visit our Health & Life Sciences blog.

    WEBINAR REPLAY:

    WEBINAR 5: What impact has Coronavirus had on doing healthcare deals?

    July 15, 2020 3 PM in British Summer Time

    The evolving European healthcare market continues to drive investment activity to record levels, however is the timing of deals being impacted by the pandemic? We hope you can join us for our fifth webinar in the HPE Europe 2020 series, where we will explore the healthcare transactional landscape in depth in our post-COVID world.

    Our panel of industry experts will address a range of issues facing healthcare investors, exploring key considerations for the savvy investor in today’s market including:

    • Have prices been impacted for healthcare assets?
    • How do investment strategies differ by health sub-sector?
    • Is a one-off impact with a V-shaped recovery expected following the pandemic?
    • What regulatory impact or changes are expected as a result of COVID-19 and how will these changes affect the deal landscape?

    Speakers

    • Marc Benatar, Partner, Apax Partners
    • Markus Peterseim, Managing Director, Head of A&M Healthcare and Life Sciences Group in Germany, Alvarez & Marsal Europe LLP

     

    Moderator

    • Tom Whelan, Partner, McDermott Will & Emery (London)

    To download key takeaways from this session, please click here.

     For highlights from our speakers, please visit our Health & Life Sciences blog.

     

    Join us and be a part of the conversation with those at the forefront of the industry who are navigating this new healthcare landscape.

    Moderators

    Hamid Yunis - Partner

    Hamid Yunis - Partner

    Chair - June 23rd Webinar

    Emmanuelle Trombe - Partner

    Emmanuelle Trombe - Partner

    Chair - June 29th Webinar

    Sharon Lamb - Partner

    Sharon Lamb - Partner

    Chair - July 7th Webinar

    Dr Stephan Rau - Partner

    Dr Stephan Rau - Partner

    Chair - July 9th Webinar

    Tom Whelan - Partner

    Tom Whelan - Partner

    Chair - July 15th Webinar

    XING


    Related Site:     McDermott+ Consulting

    Attorney Advertising ©2020 McDermott Will & Emery